Visit our social media channels
THE FIRST Ph.D DEGREE ON HADRONTHERAPY

THE HADRON ACADEMY: risk and complexity in high tech medical innovation

THE FIRST Ph.D DEGREE ON HADRONTHERAPY

AGAINST RADIO-RESISTANT AND INOPERABLE TUMORS Research THE FIRST Ph.D DEGREE ON HADRONTHERAPY

THE HADRON ACADEMY: risk and complexity in high tech medical innovation

CNAO is pleased to announce the first Ph.D degree on Hadrontherapy: THE HADRON ACADEMY: risk and complexity in high-tech medical innovation, in collaboration with the University School for Advanced Studies IUSS and the University of Cagliari.

The Ph.D degree on Hadrontherapy has a duration of 3 years, it is open and provides for 5 places/year of which: 2 covered by IUSS scholarship, 1 by scholarship funded by the University of Cagliari and 2 covered by scholarship funded by the CNAO Foundation. The application deadline is September 9, 2022 1:00 pm.
Applications are open

FOR FURTHER INFORMATION ON THE ANNOUNCEMENT OF SELECTION AND FOR APPLICATIONS

The Ph.D degree on Hadrontherapy is a path of research and training where multi-disciplinarity and trans-disciplinarity become pivotal elements for the construction of a common language through the integration of different skills.
For these reasons, year after year the doctorate provides for the proposal of doctoral theses related to research topics characterized by a strong complexity and interdisciplinarity, which will involve candidates from different disciplines, belonging to different educational macro-environments: the biomedical field (physicians, radiotherapists, biologists, biotechnologists), the technological field (physicists, engineers, data scientists), and the humanistic-social field (jurists, economists, philosophers).

Fields of research
Research activities will concern 2 main contexts: the biomedical context and the technological one

Biomedical field activities
In particular, the core of the biomedical research topics is located in the clinical rationale for the use of hadrons and the analysis of the fundamental benefit deriving from better control of the dose distribution.
This results in increased dose to the target, optimizing local disease control and/or lower dose to organs surrounding the target, while reducing the risk of radiation treatment-related toxicities.
In the case of infiltrating tumours, comparison with rival treatment plans will identify the best therapeutic dose delivery modality.
No less important are clinical considerations such as patient life expectancy being hadrons more advantageous on late toxicity.
Fundamental will be considering the role of hadrontherapy through the study of the mechanisms of interaction with immunology therapy.
Finally, there will be analysis of applications of artificial intelligence algorithms in the stages of tumour target identification and monitoring.
Studying in depth such topics is a fundamental goal in order to pursue  personalized medicine that can only be achieved with the collaboration of different professionals.

Technological  field activities
One of the goals of this field of activity is basic research applied to the biomedical sector. Because of its institutional connotation, which includes therapy and research, CNAO offers great research opportunities in the field of radiation biophysics, radiobiology, but also for applications in the space field.
At the same time, the development of new potentials for generating other heavy particles with higher intensity and energy is being investigated, in order to evaluate new ultrafast treatments by reducing detected toxicity.
But also the use of fast neutrons that will soon be available with 2 rooms, one dedicated to research and one to patient treatment. This project, Boron Neutron Capture Therapy (BNCT) constitutes an experimental form of radiation therapy based on neutron irradiation of the tumour, following perfusion with a borate drug that concentrates 10B atoms in the tumour cells. This new technique will require a multidisciplinary approach involving professional figures like physicists, engineers, chemists, biologists, and medical physicists.
Due to the complexity of the topics, doctoral theses will be offered for figures from different backgrounds with the purpose of generating a transdisciplinary approach to the management of complex problems and encourage the st-up and spread of a scientific culture related to the world of Hadrontherapy.

FOR FURTHER INFORMATION ABOUT THE ANNOUNCEMENT OF SELECTION AND FOR APPLICATIONS
 

 

  • Azienda con sistema di gestione per la Qualità Certificata
  • Centre registered with QuESTIO, the mapping of players actively operating in the field of research and innovation
  • Lombardia Life Sciences
  • ESTRO Institutional Member 2019